Chloride is an osmotic laxative sold in the U.S. under 15 brand and generic names, for hypokalemia, dehydration and hyponatremia. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.
From the FDA label for K-Tab (application NDA018279). Other chloride products — different forms, different strengths — are dosed differently. Follow the label for the one you were prescribed.
Monitor serum potassium and adjust dosages accordingly (2.1) If serum potassium is less than 2.5 mEq/L, use intravenous potassium instead of oral supplementation (2.1) Take with meals and with a glass of water or other liquid. Swallow tablets whole without crushing, chewing or sucking. (2.1) Treatment of hypokalemia : Doses range from 40 to 100 mEq/day in divided doses. Limit doses to 40 mEq per dose. (2.2) Prevention of hypokalemia : Typical dose is 20 mEq per day. (2.2) 2.1 Administration and Monitoring If serum potassium concentration is less than 2.5 mEq/L, use intravenous potassium instead of oral supplementation. Monitoring Monitor serum potassium and adjust dosages accordingly. Monitor serum potassium periodically during maintenance therapy to ensure potassium remains in desired range. The treatment of potassium depletion, particularly in the presence of cardiac disease, renal disease, or acidosis, requires careful attention to acid-base balance, volume status, electrolytes, including magnesium, sodium, chloride, phosphate, and calcium, electrocardiograms, and the clinical status of the patient. Correct volume status, acid-base balance, and electrolyte deficits as appropriate. Administration Take potassium chloride extended-release tablets with meals and with a glass of water or other liquid. Do not take potassium chloride extended-release tablets on an empty stomach…
The following adverse reactions have been identified with use of oral potassium salts. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. The most common adverse reactions to oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. There have been reports hyperkalemia and of upper and lower gastrointestinal condition including obstruction, bleeding, ulceration, perforation. Skin rash has been reported rarely. The most common adverse reactions are nausea, vomiting, flatulence, abdominal pain/discomfort and diarrhea. (6) To report SUSPECTED ADVERSE REACTIONS, contact Aurobindo Pharma USA, Inc. at 1-866-850-2876 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.
| # | Drug | Rating | Type | Form | Generic? | Typical price | |
|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Injectable | Generic | $0 | View → | |
| 2 | 70/100 | Prescription | Tablet | Generic |
Imprint codes, colour and shape from the FDA’s labelling data. Match the imprint on your pill — or search any imprint.
| Imprint | Strength | Colour | Shape | Maker |
|---|---|---|---|---|
| 020;novitium | 2 mg | brown | capsule | — |
| F;92 | 8 mg | yellow | oval | — |
| 021;novitium | 5 mg | blue, brown | capsule | — |
| PRA;5 | 5 mg | yellow, blue | capsule | — |
| G;12 | 1000 mg | white | oval | — |
| 0018;1000 | 1000 mg |
A combination is a different drug — different dosing, different warnings. It is listed here so you can find it, not so you can substitute it.
From the FDA Enforcement database. A recall covers specific lots — not the drug as a whole.
hydrOXYzine Hydrochloride Oral Solution
Presence of foreign substance
ANI Pharmaceuticals, Inc. · Jun 2, 2026
Minocycline Hydrochloride Extended-Release Tablets
Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis
Ascend Laboratories, LLC · Jun 1, 2026
Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride
Subpotent Drug
IntegraDose Compounding Services LLC · May 18, 2026
DOXOrubin Hydrochloride Liposome injection
Presence of Particulate matter: Particulate matter identified as glass.
SUN PHARMACEUTICAL INDUSTRIES INC · May 12, 2026
busPIRone Hydrochloride Tablets
Subpotent drug
Unichem Pharmaceuticals USA Inc. · Apr 13, 2026
Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.
Potassium chloride is contraindicated in patients on triamterene and amiloride. Concomitant use with triamterene and amiloride (4)
Triamterene and amiloride: Concomitant use is contraindicated (7.1) Renin-angiotensin-aldosterone inhibitors: Monitor for hyperkalemia (7.2) Nonsteroidal anti-inflammatory drugs: Monitor for hyperkalemia (7.3) 7.1 Triamterene or amiloride Use with triamterene or amiloride can produce severe hyperkalemia. Concomitant use is contraindicated [see Contraindications (4) ] . 7.2 Renin-angiotensin-aldosterone Inhibitors Drugs that inhibit the renin-angiotensin-aldosterone system (RAAS) including angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), spironolactone, eplerenone, or aliskiren produce potassium retention by inhibiting aldosterone production. Closely monitor potassium in patients on concomitant RAAS inhibitors. 7.3 Nonsteroidal Anti-inflammatory Drugs (NSAIDs) NSAIDS may produce potassium retention by reducing renal synthesis of prostaglandin E and imparing the renin-angiotensin system. Closely monitor potassium in patients on concomitant NSAIDs.
| $0 |
| View → |
| 3 | 68/100 | Prescription | Tablet | Generic | $0 | View → |
| 4 | 62/100 | Prescription | Injectable | Generic | $0 | View → |
| 5 | 42/100 | Prescription | Injectable | Generic | $0 | View → |
| 6 | Not yet rated | Prescription | Spray/Inhaler | Generic | $0 | View → |
| 7 | Not yet rated | Prescription | Tablet | Generic | $0 | View → |
| 8 | Not yet rated | Prescription | Tablet | Generic | $0 | View → |
| 9 | Not yet rated | Prescription | Tablet | Generic | $0 | View → |
| 10 | Not yet rated | Prescription | Tablet | Generic | $0 | View → |
| white |
| round |
| — |
| E114 | 450 mg | pink | oval | — |
|---|
| H;96 | 450 mg | pink | oval | — |
|---|
| REGLAN5;ANI | 5 mg | green | oval | — |
|---|
| REGLAN;ANI10 | 10 mg | white | capsule | — |
|---|
| Par;117 | 5 mg | yellow | round | — |
|---|
| P291 | 5 mg | white, yellow | diamond | — |
|---|